255 related articles for article (PubMed ID: 27000142)
21. Impact of non-motor symptoms on health-related and perceived quality of life in Parkinson's disease.
Santos-García D; de la Fuente-Fernández R
J Neurol Sci; 2013 Sep; 332(1-2):136-40. PubMed ID: 23890935
[TBL] [Abstract][Full Text] [Related]
22. Integrated multidisciplinary care in Parkinson's disease: a non-randomised, controlled trial (IMPACT).
van der Marck MA; Munneke M; Mulleners W; Hoogerwaard EM; Borm GF; Overeem S; Bloem BR;
Lancet Neurol; 2013 Oct; 12(10):947-56. PubMed ID: 23988337
[TBL] [Abstract][Full Text] [Related]
23. Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation.
Castrioto A; Lozano AM; Poon YY; Lang AE; Fallis M; Moro E
Arch Neurol; 2011 Dec; 68(12):1550-6. PubMed ID: 21825213
[TBL] [Abstract][Full Text] [Related]
24. [Direct switch from conventional levodopa to stalevo (levodopa/carbidopa/entacapone) improves quality of life in Parkinson's disease: results of an open-label clinical study].
Litvinenko IV; Odinak MM; Mogil'naia VI; Sologub OS; Sakharovskaia AA
Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(1):51-4. PubMed ID: 19156087
[TBL] [Abstract][Full Text] [Related]
25. A cost-effectiveness analysis of levodopa/carbidopa intestinal gel compared to standard care in late stage Parkinson's disease in the UK.
Lowin J; Bergman A; Chaudhuri KR; Findley LJ; Roeder C; Schifflers M; Wood E; Morris S
J Med Econ; 2011; 14(5):584-93. PubMed ID: 21728911
[TBL] [Abstract][Full Text] [Related]
26. Relationship between the non-motor items of the MDS-UPDRS and Quality of Life in patients with Parkinson's disease.
Skorvanek M; Rosenberger J; Minar M; Grofik M; Han V; Groothoff JW; Valkovic P; Gdovinova Z; van Dijk JP
J Neurol Sci; 2015; 353(1-2):87-91. PubMed ID: 25918077
[TBL] [Abstract][Full Text] [Related]
27. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
[TBL] [Abstract][Full Text] [Related]
28. A Pilot Clinical Trial to Objectively Assess the Efficacy of Electroacupuncture on Gait in Patients with Parkinson's Disease Using Body Worn Sensors.
Lei H; Toosizadeh N; Schwenk M; Sherman S; Karp S; Sternberg E; Najafi B
PLoS One; 2016; 11(5):e0155613. PubMed ID: 27227460
[TBL] [Abstract][Full Text] [Related]
29. Towards remote monitoring of Parkinson's disease tremor using wearable motion capture systems.
Delrobaei M; Memar S; Pieterman M; Stratton TW; McIsaac K; Jog M
J Neurol Sci; 2018 Jan; 384():38-45. PubMed ID: 29249375
[TBL] [Abstract][Full Text] [Related]
30. [Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment].
Jost WH; Klasser M; Reichmann H
Fortschr Neurol Psychiatr; 2008 Oct; 76(10):594-9. PubMed ID: 18833504
[TBL] [Abstract][Full Text] [Related]
31. Clinical Relevance of Standardized Mobile Gait Tests. Reliability Analysis Between Gait Recordings at Hospital and Home in Parkinson's Disease: A Pilot Study.
Gaßner H; Sanders P; Dietrich A; Marxreiter F; Eskofier BM; Winkler J; Klucken J
J Parkinsons Dis; 2020; 10(4):1763-1773. PubMed ID: 32925099
[TBL] [Abstract][Full Text] [Related]
32. Motor complications in Parkinson's disease: ten year follow-up study.
López IC; Ruiz PJ; Del Pozo SV; Bernardos VS
Mov Disord; 2010 Dec; 25(16):2735-9. PubMed ID: 20931632
[TBL] [Abstract][Full Text] [Related]
33. Prevalence, determinants, and effect on quality of life of freezing of gait in Parkinson disease.
Perez-Lloret S; Negre-Pages L; Damier P; Delval A; Derkinderen P; Destée A; Meissner WG; Schelosky L; Tison F; Rascol O
JAMA Neurol; 2014 Jul; 71(7):884-90. PubMed ID: 24839938
[TBL] [Abstract][Full Text] [Related]
34. Cabergoline versus levodopa monotherapy: a decision analysis.
Smala AM; Spottke EA; Machat O; Siebert U; Meyer D; Köhne-Volland R; Reuther M; DuChane J; Oertel WH; Berger KB; Dodel RC
Mov Disord; 2003 Aug; 18(8):898-905. PubMed ID: 12889079
[TBL] [Abstract][Full Text] [Related]
35. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA
Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
[TBL] [Abstract][Full Text] [Related]
36. Comparison of a timed motor test battery to the Unified Parkinson's Disease Rating Scale-III in Parkinson's disease.
Haaxma CA; Bloem BR; Borm GF; Horstink MW
Mov Disord; 2008 Sep; 23(12):1707-17. PubMed ID: 18649395
[TBL] [Abstract][Full Text] [Related]
37. Estimating the direct and indirect costs associated with Parkinson's disease.
Rodríguez-Blázquez C; Forjaz MJ; Lizán L; Paz S; Martínez-Martín P
Expert Rev Pharmacoecon Outcomes Res; 2015; 15(6):889-911. PubMed ID: 26511768
[TBL] [Abstract][Full Text] [Related]
38. Double-blind trial of levodopa/carbidopa/entacapone versus levodopa/carbidopa in early Parkinson's disease.
Hauser RA; Panisset M; Abbruzzese G; Mancione L; Dronamraju N; Kakarieka A;
Mov Disord; 2009 Mar; 24(4):541-50. PubMed ID: 19058133
[TBL] [Abstract][Full Text] [Related]
39. [A multi-centered randomized double-blinded controlled clinical study on efficacy of gulling pa'an capsule in treating Parkinson's disease].
Zhao GH; Meng QG; Yu XD
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2009 Jul; 29(7):590-4. PubMed ID: 19852288
[TBL] [Abstract][Full Text] [Related]
40. Motion Sensor-Based Assessment of Parkinson's Disease Motor Symptoms During Leg Agility Tests: Results From Levodopa Challenge.
Aghanavesi S; Bergquist F; Nyholm D; Senek M; Memedi M
IEEE J Biomed Health Inform; 2020 Jan; 24(1):111-119. PubMed ID: 30763248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
